65,437 trials
Scar-related Atrial Tachycardia · Paroxysmal Atrial Fibrillation · Persistent Atrial Fibrillation
Primary: Number of Participants With Serious Adverse Events (SAEs) Within 7 Days of Index Procedure Related to the OPTRELL Catheter — 0 Participants
Platinum-Resistant Fallopian Tube Carcinoma · Platinum-Resistant Ovarian Carcinoma · Platinum-Resistant Primary Peritoneal Carcinoma
Primary: Objective Response Rate (ORR) — 2; 0 Participants
Covid19
Primary: Numbers and % of Subjects Who Experience at Least 1 Treatment-emergent Adverse Event — 3; 5 Participants
Clostridium Difficile Associated Disease
Primary: Geometric Mean Concentrations (GMCs) of Clostridium Difficile Toxin A and Toxin B Specific Neutralizing Antibodies at Month 7 — 878.8; 873.0; 872.9; 5823.9…
Psychotic Disorders
Primary: Client Satisfaction Questionnaire (CSQ) — 19.2 units on a scale
D001458 · D011247
Primary: Infection Rate — 17; 18; 5; 5 Participants
Osteoporosis · HIV · Menopause
Primary: Percent Change in Bone Mineral Density From Baseline at the Lumbar Spine — 1.97; -2.32; 2.33; 0.7 Percent Change
Stroke
Primary: Center for Epidemiologic Studies - Depression (CES-D) Scale Score Among Carepartners — 9.9; 11.2; 9.1; 9.3 score on a scale
Obstructive Sleep Apnea
Primary: Performance (Mean With 95% CI) of bAHI at PSG--AHI Cutoffs of 5, 15 and 30 (Accuracy) — 0.564; 0.808; 0.910 proportion of events
Schizophrenia · Schizophreniform Disorders · Bipolar I Disorder
Primary: Percent Change From Baseline in Body Weight at Week 12 — 4.91; 6.77 Percentage of change in body weight — p=.012
Blepharitis
Primary: COHORT 1 and 2 COMBINED: Mean Change From Baseline to Day 14 in the Composite (Sum) Score of Signs & Symptoms of Blepharitis — -2.0; -1.2 units on a scale — p=0.0471
Dental Caries
Primary: the Success Rate of ACTIVA BIOACTIVE and Fuji IX Extra GIC With ART in Class I Carious Cavity of Primary Teeth — 30; 32; 28; 30 primary molars — p=0.478
Alcohol Use Disorder
Primary: Heavy Drinking Days at Baseline — 12.6; 11.7 Heavy Drinking Days
Type 2 Diabetes · Impaired Renal Function
Primary: Cellular Markers — 1.48; 2.48; 1.43; 2.4 Fold Change
Obstetrical Complications · Hemorrhage · Labor and Delivery
Primary: Number of Participants With Maternal Death or Transfusion of Packed Red Blood Cells — 201; 233 Participants — p=0.19